Rainbow Childrens Medicare Ltd Q4 FY26 Results Analysis: PAT Jumps 38%, Net Debt Doubles

Rainbow Childrens Medicare Ltd's Q4 FY26 numbers came in mixed, with revenue of Rs. 459.90 Cr (+24.30% YoY) and PAT growth of +38.30% YoY. Here's a quick read of what worked, what to watch, and what management said.

Quarter Snapshot

Consolidated revenue grew 24.3% YoY in Q4 and PAT 38.3%, driven by strong execution and subsidiary contributions. However, margin compression (EBITDA -40 bps for FY26), rapid receivables growth (+40.5%), and elevated capex (Rs.2,165 Mn) leading to net debt doubling temper the performance. No management guidance was provided for cross-referencing, limiting assessment of beats vs internal targets.

Key Investment Insights

Key Positives

• Consolidated revenue grew 24.3% YoY in Q4 FY26, the strongest growth quarter of the year
• Consolidated PAT grew 38.3% YoY in Q4 and 15.3% for full year FY26
• Operating cash flow at 1.49x of PAT, indicating high earnings quality
• Finance costs grew 530 bps slower than revenue, demonstrating operating leverage
• Subsidiaries contributed 9.2% incremental revenue and 11.2% incremental PAT, diversifying growth

Risk Factors

• Cost of materials consumed grew 410 bps faster than revenue, indicating gross margin pressure
• EBITDA margin compressed 40 bps for FY26 and 290 bps sequentially in Q4
• Trade receivables grew 40.5% vs revenue growth of 12.4%, signaling potential collection issues
• Net debt increased 122.4% to Rs.4,960 Mn as cash deployed for capex and acquisition
• Effective tax rate fell to 21.4% in FY26 due to deferred tax credits, boosting reported PAT